Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. FDA Considers Using Third-Party Inspectors to Enhance Global Reach

This article was originally published in PharmAsia News

Executive Summary

U.S. FDA is talking about adding an outsourced inspectorate to help it police the globally outsourced pharmaceutical manufacturing industry

Related Content

User Fee Bill Puts Industry, U.S. FDA to Work On Global Supply Chain Risks
Is Silence Golden For Brand Companies On Inspection Fees?
FDA-EMA-TGA Joint Inspection Program To Be Permanent; Other Collaborations Expand
‘Global Allegiance’ of Inspectorates Emerging
‘Global Allegiance’ of Inspectorates Emerging
Heparin Adulteration Triggered Pharmaceutical Identity Crisis



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts